{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T17:07:36Z","timestamp":1725469656720},"publisher-location":"Chichester, UK","reference-count":95,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006133.pub3","type":"reference-entry","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T18:29:12Z","timestamp":1256149752000},"source":"Crossref","is-referenced-by-count":13,"title":["Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus"],"prefix":"10.1002","author":[{"given":"Laureen M","family":"Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth F","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"key":"10.1002\/14651858.CD006133.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0010-7824(90)90036-U","article-title":"Comparison of two triphasic contraceptives with different progestogens: effects on metabolism and coagulation proteins","volume":"41","author":"Ball","year":"1990","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0010-7824(91)90014-7","article-title":"Progestagen-only oral contraceptives: comparison of the metabolic effects of levonorgestrel and norethisterone","volume":"44","author":"Ball","year":"1991","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0010-7824(93)90141-S","article-title":"Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel","volume":"48","author":"Basdevant","year":"1993","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0010-7824(97)00033-4","article-title":"Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and TriNovum","volume":"55","author":"Benagiano","year":"1997","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0010-7824(01)00182-2","article-title":"Implanon contraceptive implants: effects on carbohydrate metabolism","volume":"63","author":"Biswas","year":"2001","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB6|cit6","first-page":"568","article-title":"The effect of cyclical administration of levonorgestrel and ethinyloestradiol on blood pressure, body mass, blood glucose and serum triglycerides","volume":"56","author":"Bloch","year":"1979","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD006133.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/0002-9378(89)90704-7","article-title":"Triphasic Randomized Clinical Trial: Comparison of effects on carbohydrate metabolism","volume":"161","author":"Bowes","year":"1989","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006133.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/0002-9378(89)90702-3","article-title":"Study design for the Triphasic Randomized Clinical Trial","volume":"161","author":"Dickerson","year":"1989","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006133.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.contraception.2008.09.002","article-title":"Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial","volume":"79","author":"Cagnacci","year":"2009","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB10|cit10","doi-asserted-by":"crossref","unstructured":"Cagnacci A Ferrari S Tirelli A Zanin R Volpe A Route of administration of contraceptives containing desogestrel\/etonogestrel and insulin sensitivity. A prospective randomized study Contraception 2009","DOI":"10.1016\/j.contraception.2009.01.012"},{"key":"10.1002\/14651858.CD006133.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13625180400007199","article-title":"A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function","volume":"9","author":"Duijkers","year":"2004","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD006133.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.contraception.2007.08.001","article-title":"Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive","volume":"76","author":"Elkind-Hirsch","year":"2007","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0010-7824(01)00316-X","article-title":"An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 \u00b5g ethinyl estradiol and 100 \u00b5g levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables","volume":"65","author":"Endrikat","year":"2002","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0010-7824(91)90032-B","article-title":"Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile","volume":"44","author":"Fahmy","year":"1991","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0010-7824(02)00537-1","article-title":"A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism","volume":"67","author":"Gaspard","year":"2003","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB16|cit16","first-page":"108","article-title":"Effect of long-term triphasic oral contraceptive use on glucose tolerance and insulin secretion","volume":"78","author":"Gillespy","year":"1991","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006133.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0002-9378(90)90586-V","article-title":"Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial","volume":"163","author":"Jandrain","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006133.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/ejc.6.2.71.77","article-title":"The effects of two progestogen-only pills containing either desogestrel (75 \u00b5g\/day) or levonorgestrel (30 \u00b5g\/day) on carbohydrate metabolism and adrenal and thyroid function","volume":"6","author":"Kivela","year":"2001","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD006133.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2004.12.005","article-title":"Effects of two combined oral contraceptives containing ethinyl estradiol 20 \u00b5g combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism","volume":"71","author":"Klipping","year":"2005","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(00)00196-7","article-title":"Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel","volume":"63","author":"Knopp","year":"2001","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0010-7824(85)90119-2","article-title":"A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters: II. Effects upon thyroid function, gastrin, STH, and glucose tolerance","volume":"32","author":"Kuhl","year":"1985","journal-title":"Contraception"},{"issue":"Suppl","key":"10.1002\/14651858.CD006133.pub3-BIB22|cit22","first-page":"15","article-title":"Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene","volume":"32","author":"Lepot","year":"1987","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD006133.pub3-BIB23|cit23","first-page":"45","article-title":"Blood glucose, serum insulin, serum growth hormone and serum glycosylated proteins during two years' oral contraception with low-estrogen combinations","volume":"202","author":"Liukko","year":"1987","journal-title":"Annales Chirurgiae at Gynaecologiae Supplement"},{"key":"10.1002\/14651858.CD006133.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0010-7824(92)90004-D","article-title":"Lipid and biochemical changes after low-dose oral contraception","volume":"46","author":"Loke","year":"1992","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0010-7824(02)00415-8","article-title":"Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism","volume":"66","author":"Ludicke","year":"2002","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB26|cit26","series-title":"Advances in fertility control and the treatment of sterilty. Proceedings of a Special Symposium held at the XIth World Congress on Fertility and Sterility; 1983 June; Dublin","first-page":"107","article-title":"Carbohydrate metabolism alterations with monphasic, sequential and triphasic oral contraceptives containing ethinyl-oestradiol plus levonorgestrel or desogestrel","author":"Gaspard","year":"1984"},{"key":"10.1002\/14651858.CD006133.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0015-0282(16)49334-9","article-title":"Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study","volume":"45","author":"Luyckx","year":"1986","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006133.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0010-7824(89)90039-5","article-title":"Metabolic effects of three new low-dose pills: a six-month experience","volume":"39","author":"Miccoli","year":"1989","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB29|cit29","first-page":"441","article-title":"Effects of low-dose oral contraceptives on sugar metabolism","volume":"41","author":"Miccoli","year":"1989","journal-title":"Minerva Ginecologica"},{"key":"10.1002\/14651858.CD006133.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5144\/0256-4947.1999.8","article-title":"A comparative analysis of three methods of contraception; effects on blood glucose and serum lipid profiles","volume":"19","author":"Mostafavi","year":"1999","journal-title":"Annals of Saudi Medicine"},{"key":"10.1002\/14651858.CD006133.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1210\/jc.80.6.1816","article-title":"Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD006133.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/j.1600-0412.1999.780515.x","article-title":"The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1","volume":"78","author":"Pakarinen","year":"1999","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD006133.pub3-BIB33|cit33","first-page":"666","article-title":"Desogestrel and gestodene in oral contraceptives: 12 months' assessment of carbohydrate and lipoprotein metabolism","volume":"78","author":"Petersen","year":"1991","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD006133.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0010-7824(99)00107-9","article-title":"Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives","volume":"60","author":"Petersen","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0010-7824(89)90013-9","article-title":"Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women","volume":"39","author":"Prasad","year":"1989","journal-title":"Contraception"},{"issue":"Suppl","key":"10.1002\/14651858.CD006133.pub3-BIB36|cit36","first-page":"29","article-title":"Clinical and metabolic effects of gestodene and levonorgestrel","volume":"32","author":"Rabe","year":"1987","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD006133.pub3-BIB37|cit37","first-page":"630","article-title":"Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance","volume":"35","author":"R\u00e1k\u00f3czi","year":"1985","journal-title":"Arzneimittel-Forschung"},{"key":"10.1002\/14651858.CD006133.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.contraception.2004.01.003","article-title":"Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene","volume":"69","author":"Rechberger","year":"2004","journal-title":"Contraception"},{"issue":"5 Pt 2","key":"10.1002\/14651858.CD006133.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9378(99)70363-7","article-title":"A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 \u00b5g levonorgestrel with 20 \u00b5g ethinyl estradiol or triphasic norethindrone with ethinyl estradiol","volume":"181","author":"Reisman","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006133.pub3-BIB40|cit40","unstructured":"Abd-Rabbo MD Toppozada HK Abou-El-Einen MA Sadek W Comparative study of the biochemical effects of combined estrogen\/progestogen oral contraceptives containing less than 50 micrograms of estrogen Presented at the First Annual Meeting of the Society for the Advancement of Contraception, Cairo, November 5-9, 1983"},{"key":"10.1002\/14651858.CD006133.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0010-7824(85)90046-0","article-title":"A randomized double-blind study of the effects of two low-dose combined oral contraceptives on biochemical aspects. Report from a seven-centred study. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives","volume":"32","author":"Sadik","year":"1985","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.contraception.2004.08.017","article-title":"A 1-yr randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 \u00b5g ethinyl estradiol combined with 100 \u00b5g levonorgesterel","volume":"71","author":"Skouby","year":"2005","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0010-7824(92)90103-Z","article-title":"A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel","volume":"45","author":"Song","year":"1992","journal-title":"Contraception"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006133.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/13625189909085267","article-title":"A comparative study of the effects of gestodene 60 \u00b5g\/ethinylestradiol 15 \u00b5g and desogestrel 150 \u00b5g\/ethinylestradiol 20 \u00b5g on hemostatic balance, blood lipid levels and carbohydrate metabolism","volume":"4","author":"Mooren","year":"1999","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD006133.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/0002-9378(87)90355-3","article-title":"Effect of seven low-dose combined oral contraceptive preparations on carbohydrate metabolism","volume":"156","author":"Vange","year":"1987","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006133.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0010-7824(97)00139-X","article-title":"Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism","volume":"56","year":"1997","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0010-7824(98)00003-1","article-title":"Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on glucose metabolism and liver function","volume":"57","year":"1998","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.contraception.2008.08.011","article-title":"The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters","volume":"79","author":"Winkler","year":"2009","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0010-7824(88)90018-2","article-title":"A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users","volume":"37","author":"Amatayakul","year":"1988","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0010-7824(76)80040-6","article-title":"The effect of various contraceptive hormonal therapies in women with normal and diabetic oral glucose tolerance test","volume":"13","author":"Aznar","year":"1976","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0010-7824(84)90079-9","article-title":"Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins","volume":"30","author":"Bergink","year":"1984","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB52|cit52","series-title":"The development of a new triphasic oral contraceptive. Proceedings of a Special Symposium held at the 10th World Congress on Fertility and Sterility; 1980 July; Madrid","first-page":"79","article-title":"A randomized study of metabolic effects of four oral contraceptive preparations containing levonorgestrel plus ethinylestradiol in different regimens","author":"Briggs","year":"1980"},{"key":"10.1002\/14651858.CD006133.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/00016348209155314","article-title":"Randomized prospective studies on metabolic effects of oral contraceptives","volume":"105","author":"Briggs","year":"1982","journal-title":"Acta Obstetrica et Gynecologica Scandinavica Supplement"},{"key":"10.1002\/14651858.CD006133.pub3-BIB54|cit54","first-page":"5","article-title":"Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimate","volume":"156","author":"Burkman","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD006133.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0010-7824(01)00236-0","article-title":"A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 30 microg ethinyl estradiol and 75 microg gestodene on hemostatic variables, lipids, and carbohydrate metabolism","volume":"64","author":"Endrikat","year":"2001","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB56|cit56","first-page":"155","article-title":"Effect of oral contraceptive containing a new progestin (Org 2969) on plasma renin activity, growth hormone and immunoreactive insulin","volume":"68","author":"Liukko","year":"1979","journal-title":"Annales Chirurgiae at Gynaecologiae"},{"key":"10.1002\/14651858.CD006133.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0010-7824(77)90051-8","article-title":"Serum protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy","volume":"16","author":"Saleh","year":"1977","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0015-0282(16)38880-X","article-title":"The effects of medroxyprogesterone acetate on carbohydrate metabolism: measurements of glucose, insulin, and growth hormone after twelve months' use","volume":"23","author":"Spellacy","year":"1972","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006133.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01849493","article-title":"Two-year carbohydrate metabolism studies in women using a norethindrone or levonorgestrel triphasic oral contraceptive","volume":"6","author":"Spellacy","year":"1990","journal-title":"Advances in Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0015-0282(16)60431-4","article-title":"The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use","volume":"51","author":"Spellacy","year":"1989","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006133.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00004872-199816030-00013","article-title":"A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women","volume":"16","author":"Straznicky","year":"1998","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD006133.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/13625189709167473","article-title":"A randomized cross-over study comparing pharmacodynamic and metabolic variables of a new combiphasic and a well-established triphasic oral contraceptive","volume":"2","author":"Ende","year":"1997","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD006133.pub3-BIB63|cit63","unstructured":"NCT00248963 Study evaluating levonorgestrel and ethinyl estradiol in oral contraception http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00248963"},{"key":"10.1002\/14651858.CD006133.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1097\/00006250-200604001-00027","article-title":"Comparative trial of continuous-use and 21-day cyclic levonorgestrel and ethinyl estradiol oral contraceptive (abstract)","volume":"107","author":"Teichmann","year":"2006","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006133.pub3-BIB65|cit65","unstructured":"NCT00439972 Oral versus patch hormonal contraceptive effects on metabolism, clotting, inflammatory factors and vascular reactivity http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00439972"},{"key":"10.1002\/14651858.CD006133.pub3-BIB66|cit66","unstructured":"NCT00511355 Effects on hemostasis, lipids, carbohydrate metabolism, adrenal & thyroid function of the combined oral contraceptive NOMAC-E2 compared to a COC containing LNG-EE http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00511355"},{"key":"10.1002\/14651858.CD006133.pub3-BIB67|cit67","unstructured":"NCT00827632 Obesity, oral contraception, and ovarian suppression http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00827632"},{"key":"10.1002\/14651858.CD006133.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.annepidem.2004.10.009","article-title":"The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth","volume":"15","author":"Brunner","year":"2005","journal-title":"Annals of Epidemiology"},{"key":"10.1002\/14651858.CD006133.pub3-BIB69|cit69","unstructured":"Centers for Disease Control and Prevention Overweight and Obesity http:\/\/www.cdc.gov\/nccdphp\/dnpa\/obesity\/"},{"key":"10.1002\/14651858.CD006133.pub3-BIB70|cit70","unstructured":"CONSORT group CONSORT: Transparent reporting of trials http:\/\/www.consort-statement.org\/"},{"key":"10.1002\/14651858.CD006133.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD006133.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0010-7824(01)00290-6","article-title":"Metabolic effects of implantable steroid contraceptives for women","volume":"65","author":"Dorflinger","year":"2002","journal-title":"Contraception"},{"issue":"4","key":"10.1002\/14651858.CD006133.pub3-BIB73|cit73","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003987.pub3","article-title":"Combination contraceptives: effects on weight","author":"Gallo","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006133.pub3-BIB74|cit74","first-page":"157","article-title":"Injectable contraceptives","volume-title":"Contraceptive Technology","author":"Goldberg","year":"2007"},{"key":"10.1002\/14651858.CD006133.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2005.04.002","article-title":"Family planning for obese women: challenges and opportunities","volume":"72","author":"Grimes","year":"2005","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006133.pub3-BIB76|cit76","first-page":"101","article-title":"Pharmacology of progestins: 17alpha-hydroxyprogesterone derivatives and progestins of the first and second generation","volume-title":"Progestins and Antiprogestins in Clinical Practice","author":"Henzl","year":"2000"},{"key":"10.1002\/14651858.CD006133.pub3-BIB77|cit77","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] www.cochrane.dk\/cochrane\/handbook\/hbook.htm"},{"key":"10.1002\/14651858.CD006133.pub3-BIB78|cit78","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 [updated Feb 2008] Available from www.cochrane-handbook.org 2008","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD006133.pub3-BIB79|cit79","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2337\/diacare.26.1.216","article-title":"Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk","volume":"26","author":"Kahn","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD006133.pub3-BIB80|cit80","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0002-8223(21)00894-4","article-title":"Comparison of body mass indexes and cutoff points for estimating the prevalence of overweight in Hispanic women","volume":"92","author":"Lopez","year":"1992","journal-title":"Journal of the American Dietetic Association"},{"volume-title":"Safety Requirements for Contraceptive Steroids","year":"1989","author":"Michal","key":"10.1002\/14651858.CD006133.pub3-BIB81|cit81"},{"key":"10.1002\/14651858.CD006133.pub3-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006133.pub3-BIB83|cit83","first-page":"193","article-title":"Combined oral contraceptives","volume-title":"Contraceptive Technology","author":"Nelson","year":"2007"},{"key":"10.1002\/14651858.CD006133.pub3-BIB84|cit84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1467-789X.2005.00189.x","article-title":"Ethnic comparisons of obesity in the Asia-Pacific region: protocol for a collaborative overview of cross-sectional studies","volume":"6","year":"2005","journal-title":"Obesity Reviews"},{"key":"10.1002\/14651858.CD006133.pub3-BIB85|cit85","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.nutr.24.012003.132155","article-title":"The insulin resistance syndrome: definition and dietary approaches to treatment","volume":"25","author":"Reaven","year":"2005","journal-title":"Annual Review of Nutrition"},{"key":"10.1002\/14651858.CD006133.pub3-BIB86|cit86","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/357434a0","article-title":"Reflections of a whistle-blower","volume":"357","author":"Rossiter","year":"1992","journal-title":"Nature"},{"key":"10.1002\/14651858.CD006133.pub3-BIB87|cit87","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD006133.pub3-BIB88|cit88","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006133.pub3-BIB89|cit89","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(02)07882-0","article-title":"Sample size slippages in randomised trials: exclusions and the lost and wayward","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006133.pub3-BIB90|cit90","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2005","journal-title":"Human Reproduction Update"},{"volume-title":"Evidence-based Medicine: How to Practice and Teach EBM","year":"2005","author":"Strauss","key":"10.1002\/14651858.CD006133.pub3-BIB91|cit91"},{"key":"10.1002\/14651858.CD006133.pub3-BIB92|cit92","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/S0140-6736(05)67341-2","article-title":"Preventing chronic diseases: how many lives can we save?","volume":"366","author":"Strong","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD006133.pub3-BIB93|cit93","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003990.pub3","article-title":"Hormonal versus non-hormonal contraceptives in women with diabetes mellitus","author":"Visser","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"volume-title":"Modern Oral Contraception. Updates from the Contraception Report","year":"2000","author":"Wallach","key":"10.1002\/14651858.CD006133.pub3-BIB94|cit94"},{"key":"10.1002\/14651858.CD006133.pub3-BIB95|cit95","unstructured":"World Health Organization Medical Eligibility Criteria for Contraceptive Use. Third edition - 2004 http:\/\/www.who.int\/reproductive-health\/publications\/mec\/"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006133.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T18:30:12Z","timestamp":1634063412000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006133.pub3"}},"subtitle":[],"editor":[{"given":"Laureen M","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,7]]},"references-count":95,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006133.pub3","relation":{},"subject":[],"published":{"date-parts":[[2009,10,7]]}}}